Evelo Biosciences is doing pretty well for a preclinical company in an exploratory field. The 2014 startup has already executed a merger and raised $100 million in venture financing for its so-called "monoclonal microbials."
In medicine, the microbiome is most often associated with the gut. But there are millions of bacteria, viruses and fungi that live on our skin and in our glands, too, and scientists suspect that learning more about them could lead to better diagnosis and treatment of skin conditions. A Cambridge biotech startup called AOBiome is […]
Scientific understanding of the microbiome – the ecosystem of bacteria in the gut – has matured to the point where the pharmaceutical industry recognizes it as a critical part of drug discovery, says Peter DiLaura, CEO of Second Genome. “The microbiome certainly is not the total picture of disease, but there’s now recognition that you […]
In the same way that great advances in our understanding of the human genome sparked new opportunities for biotech companies in the early 2000s, growing knowledge about how microbes in the human body affect health has paved the way for a small class of biotech startups emerging now. These companies are looking at ways to […]
The human body is full of trillions of microorganisms that keep us functioning and healthy. But when the normal ecosystems in which these microorganisms live are disturbed, they can become harmful. A new startup out of VentureLabs, the arm of Flagship Ventures that invents and launches new companies, is turning to imbalances in the body’s […]
